|
End-of-day quote
Buenos Aires S.E.
16/09/2026
|
5-day change | 1st Jan Change | ||
| 1,550.00 ARS | -0.96% |
|
-2.21% | -21.52% |
| Market Cap | 125B 83.02M 71.95M 68M 61.74M 116M 7.96B 116M 812M 314M 4.04B 312M 305M 12.88B | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 356B 236M 205M 194M 176M 329M 22.67B 331M 2.31B 893M 11.5B 888M 868M 36.64B | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
| 1 day | -0.96% | ||
| 1 week | -2.21% | ||
| Current month | -3.73% | ||
| 1 month | -0.32% | ||
| 3 months | -0.96% | ||
| 6 months | -9.88% | ||
| Current year | -21.52% |
| 1 week | 1,505 | 1,620 | |
| 1 month | 1,495 | 1,635 | |
| Current year | 1,420 | 2,130 | |
| 1 year | 945 | 2,300 | |
| 3 years | 480.5 | 2,300 | |
| 5 years | 215 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 29/04/2025 | |
| Corporate Officer/Principal | - | 29/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.96% | -2.21% | +42.86% | +184.93% | 83.82M | ||
| +0.15% | +1.21% | +48.79% | +97.65% | 1,013B | ||
| +0.03% | +0.07% | +51.47% | +65.55% | 644B | ||
| -0.20% | +4.62% | +21.39% | +72.57% | 465B | ||
| +0.53% | +4.26% | +40.29% | +38.70% | 352B | ||
| +0.39% | +2.35% | +17.96% | +23.87% | 264B | ||
| +0.17% | +4.17% | +6.96% | +10.93% | 253B | ||
| +0.19% | -3.81% | +37.81% | +44.35% | 203B | ||
| -1.20% | -5.64% | -24.09% | -59.10% | 188B | ||
| +0.94% | +1.39% | +33.21% | +95.16% | 181B | ||
| Average | +0.00% | -0.65% | +27.67% | +57.46% | 356.38B | |
| Weighted average by Cap. | +0.11% | +0.32% | +34.33% | +59.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 91.79B 60.89M 52.77M 49.87M 45.28M 84.86M 5.84B 85.36M 595M 230M 2.96B 229M 224M 9.44B | 127B 84.06M 72.84M 68.85M 62.51M 117M 8.06B 118M 822M 318M 4.09B 316M 309M 13.04B |
| Net income | 23.85B 15.82M 13.71M 12.96M 11.76M 22.04M 1.52B 22.17M 155M 59.76M 770M 59.42M 58.1M 2.45B | 3.09B 2.05M 1.77M 1.68M 1.52M 2.85M 196M 2.87M 20.03M 7.74M 99.66M 7.69M 7.52M 318M |
| Net Debt | 134B 88.65M 76.82M 72.61M 65.92M 124M 8.5B 124M 867M 335M 4.31B 333M 326M 13.75B | 231B 153M 133M 126M 114M 214M 14.7B 215M 1.5B 579M 7.46B 576M 563M 23.77B |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/09/26 | ARS 1,550.00 | -0.96% | 374 |
| 15/09/26 | ARS 1,565.00 | -0.63% | 8,455 |
| 14/09/26 | ARS 1,575.00 | +0.64% | 1,851 |
| 11/09/26 | ARS 1,565.00 | 0.00% | 394 |
| 10/09/26 | ARS 1,565.00 | -1.26% | 703 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions
















